Coronavirus pandemic has intensely affected the worldwide network. The COVID- 19 virulent disease cause by the SARSCoV- 2 has been an extraordinary global health challenge. Through the 24,193,010 globally disturbing 216 countries and 826,141 deaths, because of August 27, 2020. In India, there are 3,310,234 cases with 60,472 deaths. Given the unprecedented magnitude of the pandemic’s impact on health and economy, therapies for COVID-19 are being actively investigated, and there are quite 1000 treatment and over 173 vaccine trials taking place worldwide, including 31 candidate vaccines in clinical evaluation and 142 in pre-clinical evaluation. As of late, the antiviral specialist’s remdesivir and favipiravir, which act by repressing viral replication, have been endorsed for COVID-19 treatment in seriously sick patients by the Government of India.
Write a Review
To write a review, please login to your Pothi.com account.
COVID -19 CLINICAL FEATURES
Coronavirus pandemic
has intensely affected the worldwide network. The COVID-
19 virulent disease cause by the SARSCoV- 2 has been an
extraordinary global health challenge. Through the
24,193,010 globally disturbing 216 countries and 826,141
deaths, because of August 27, 2020. In India, there are
3,310,234 cases with 60,472 deaths. Given the
unprecedented magnitude of the pandemic’s impact on
health and economy, therapies for COVID-19 are being
actively investigated, and there are quite 1000 treatment
and over 173 vaccine trials taking place worldwide,
including 31 candidate vaccines in clinical evaluation and
142 in pre-clinical evaluation. As of late, the antiviral
specialist’s remdesivir and favipiravir, which act by
repressing viral replication, have been endorsed for
COVID-19 treatment in seriously sick patients by the
Government of India.